Sodium iodide i 131
Hicon, Iodide I (sodium iodide i 131) is a small molecule pharmaceutical. Sodium iodide i 131 was first approved as Sodium iodide i 131 on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| colloidal iodine solution | unapproved drug other | 2023-05-23 |
| cvs iodine | C200263 | 2023-12-20 |
| ddm iodine tincture mild | C200263 | 2023-12-19 |
| de la cruz tincture of iodine | C200263 | 2023-12-15 |
| foster and thrive 2% mild iodine tincture | C200263 | 2024-12-17 |
| gnp idoinde tincture 2% mild | C200263 | 2023-12-14 |
| harris teeter iodine tincture mild | C200263 | 2023-12-20 |
| health mart iodine tincture mild | C200263 | 2023-12-20 |
| hicon | New Drug Application | 2025-01-21 |
| iodine tincture mild | C200263 | 2023-12-15 |
Show 11 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
14 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Thyroid diseases | D013959 | — | E00-E07 | 2 | 3 | 1 | — | 3 | 8 |
| Thyroid neoplasms | D013964 | EFO_0003841 | — | 1 | 4 | 1 | — | 2 | 7 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Papillary thyroid cancer | D000077273 | — | — | 1 | 1 | — | — | — | 2 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | — | 1 | — | — | — | 1 |
| Lymphoma | D008223 | — | C85.9 | — | 1 | — | — | — | 1 |
| Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
| Follicular adenocarcinoma | D018263 | — | — | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Head and neck neoplasms | D006258 | — | — | 1 | — | — | — | — | 1 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | — | — | — | — | 3 | 3 |
| Tachycardia | D013610 | — | R00.0 | — | — | — | — | 3 | 3 |
| Syndrome | D013577 | — | — | — | — | — | — | 3 | 3 |
| Hypothyroidism | D007037 | EFO_0004705 | E03.9 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Sodium iodide i 131 |
| INN | sodium iodide (131i) |
| Description | Hicon (sodium iodide i 131) is a small molecule pharmaceutical. Sodium iodide i 131 was first approved as Sodium iodide i 131 on 1982-01-01. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | [131I-].[Na+] |
Identifiers
| PDB | — |
| CAS-ID | 7790-26-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201084 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 29VCO8ACHH (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
Black-box warning for: Nestabs, Nestabs dha, Pre-tabs dha, Prenate pixie
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
131 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use